Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Education
Utilising The Social Return On Investment (Sroi) Framework To Gauge Social Value In The Fast Forward Program, Jioji Ravulo, Shannon Said, Jim Micsko, Gayl Purchase
Utilising The Social Return On Investment (Sroi) Framework To Gauge Social Value In The Fast Forward Program, Jioji Ravulo, Shannon Said, Jim Micsko, Gayl Purchase
Faculty of Social Sciences - Papers (Archive)
A market paradigm shift towards a 'knowledge-based economy' means Australia is moving towards a major skills crisis whereby the workforce will lack skills attainable from higher education. Moreover, those from low socio-economic backgrounds, and who are confronted with disadvantage, still face challenges in gaining entry to university. The Fast Forward Program (FFP) aims to increase attainment of higher education for greater western Sydney high school students in years 9-12, with a focus on dismantling the social barriers preventing attainment. To achieve this aim, the program hosts a range of student and parent in-school workshops and on-campus visits. To capture the …
Post‐Marketing Studies Of Pharmaceutical Opioid Abuse‐Deterrent Formulations: A Framework For Research Design And Reporting, Amy Peacock, Briony K. Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A. Buckley, Michael P. Farrell, Louisa Degenhardt
Post‐Marketing Studies Of Pharmaceutical Opioid Abuse‐Deterrent Formulations: A Framework For Research Design And Reporting, Amy Peacock, Briony K. Larance, Raimondo Bruno, Sallie-Anne Pearson, Nicholas A. Buckley, Michael P. Farrell, Louisa Degenhardt
Faculty of Social Sciences - Papers (Archive)
Background and aims Opioid formulations with properties to deter abuse (abuse‐deterrent formulations; ADFs) have been developed as one response to the prescription opioid 'epidemic'. As for all medicines, ADFs undergo evaluation of safety and efficacy prior to registration for marketing. However, reduced extra‐medical use (the primary intended outcome of ADFs and reason for their introduction) can only be established in post‐marketing observational studies, comparing them to opioid formulations without abuse‐deterrent properties. This has implications for various features of study design and analysis. We discuss proposals for the design, conduct, governance and reporting of post‐marketing studies on the effectiveness of pharmaceutical …